Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Mad-Helenie Elsensohn"'
Autor:
Hélène Lasolle, Mad-Hélénie Elsensohn, Anne Wierinckx, Eudeline Alix, Clément Bonnefille, Alexandre Vasiljevic, Christine Cortet, Bénédicte Decoudier, Nathalie Sturm, Stephan Gaillard, Amandine Ferrière, Pascal Roy, Emmanuel Jouanneau, Philippe Bertolino, Claire Bardel, Damien Sanlaville, Gérald Raverot
Publikováno v:
Acta Neuropathologica Communications, Vol 8, Iss 1, Pp 1-14 (2020)
Abstract The purpose of this study was to analyze the impact of copy number variations (CNV) on sporadic pituitary neuroendocrine tumors (PitNETs) prognosis, to identify specific prognosis markers according to the known clinico-pathological classific
Externí odkaz:
https://doaj.org/article/bad74d408c3644daa9aeac245f2ab195
Autor:
Yasodha Natkunam, Daphne de Jong, Pedro Farinha, Philippe Gaulard, Wolfram Klapper, Andreas Rosenwald, Birgitta Sander, Reuben Tooze, Ranjana Advani, Catherine Burton, John G Gribben, Marie‐José Kersten, Eva Kimby, Georg Lenz, Thierry Molina, Franck Morschhauser, David Scott, Laurie Sehn, Wendy Stevens, Andrew Clear, Maryse Baia, Abdelmalek Habi, Mad‐Helenie Elsensohn, Carole Langlois‐Jacques, Delphine Maucort‐Boulch, Maria Calaminici
Publikováno v:
Histopathology, 82(7), 1105-1111. Wiley-Blackwell
Histopathology, 82, 7, pp. 1105-1111
Natkunam, Y, de Jong, D, Farinha, P, Gaulard, P, Klapper, W, Rosenwald, A, Sander, B, Tooze, R, Advani, R, Burton, C, Gribben, J G, Kersten, M-J, Kimby, E, Lenz, G, Molina, T, Morschhauser, F, Scott, D, Sehn, L, Stevens, W, Clear, A, Baia, M, Habi, A, Elsensohn, M-H, Langlois-Jacques, C, Maucort-Boulch, D & Calaminici, M 2023, ' Lack of reproducibility of histopathological features in MYC-rearranged large B cell lymphoma using digital whole slide images : a study from the Lunenburg lymphoma biomarker consortium ', Histopathology, vol. 82, no. 7, pp. 1105-1111 . https://doi.org/10.1111/his.14896
Histopathology, 82, 7, pp. 1105-1111
Natkunam, Y, de Jong, D, Farinha, P, Gaulard, P, Klapper, W, Rosenwald, A, Sander, B, Tooze, R, Advani, R, Burton, C, Gribben, J G, Kersten, M-J, Kimby, E, Lenz, G, Molina, T, Morschhauser, F, Scott, D, Sehn, L, Stevens, W, Clear, A, Baia, M, Habi, A, Elsensohn, M-H, Langlois-Jacques, C, Maucort-Boulch, D & Calaminici, M 2023, ' Lack of reproducibility of histopathological features in MYC-rearranged large B cell lymphoma using digital whole slide images : a study from the Lunenburg lymphoma biomarker consortium ', Histopathology, vol. 82, no. 7, pp. 1105-1111 . https://doi.org/10.1111/his.14896
Contains fulltext : 294569.pdf (Publisher’s version ) (Open Access) AIMS: Subclassification of large B cell lymphoma (LBCL) is challenging due to the overlap in histopathological, immunophenotypical and genetic data. In particular, the criteria to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9cba061497775117612f7d4ea557642d
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85150932636&origin=inward
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85150932636&origin=inward
Autor:
Antonio Farina, Cristina Birzu, Mad-Helenie Elsensohn, Alberto Picca, Sergio Muñiz-Castrillo, Alberto Vogrig, Macarena Villagrán-García, Nicolás Lundahl Ciano-Petersen, Luca Massacesi, Baptiste Hervier, Sarah Guégan, Nora Kramkimel, Yann Vano, Joe Elie Salem, Yves Allenbach, Thierry Maisonobe, Souad Assaad, Aurélien Maureille, Perrine Devic, Nicolas Weiss, Antoine Pegat, Delphine Maucort-Boulch, Damien Ricard, Jérôme Honnorat, Dimitri Psimaras, Bastien Joubert
Publikováno v:
Brain Communications.
While the spectrum of neurological immune checkpoint inhibitor-related adverse events is expanding, patients’ outcomes are not well documented. This study aimed to assess outcomes of neurological immune-related adverse events and to identify progno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fa15a2e5be96e91285f58bf3d6f1e132
https://doi.org/10.1093/braincomms/fcad169
https://doi.org/10.1093/braincomms/fcad169
Autor:
Anne-Sophie Michallet, Anne Quinquenel, Remi Letestu, Magali Le Garff-Tavernier, Fabien Subtil, Mad-Helenie Elsensohn, Therese Aurran, Kamel Laribi, Florence Cymbalista, Vincent Levy, Laurence Simon, Damien Roos-Weil, Veronique Leblond, Marie-Sarah Dilhuydy, Cécile Tomowiak, Caroline Dartigeas, Romain Guieze, Olivier Tournilhac, Emmanuelle Ferrant, Sophie de Guibert, Pierre Feugier, Fatiha Merabet, Stéphane Leprêtre, Philippe Carassou, Julie Gay, Bénédicte Hivert, Luc Mathieu Fornecker, Jehan Dupuis, Lysiane Molina, Bruno Villemagne, Guillaume Cartron, Bernard Drenou, Béatrice Mahé, Omar Benbrahim, Xavier Cahu, Christelle Portois, Loic Ysebaert, Florence Nguyen-Khac, Valérie Rouille, Alain Delmer
Publikováno v:
Blood. 138:641-641
With the emergence of targeted therapies, defining the best strategy for the treatment of previously untreated CLL patients remains challenging. The aim of this phase 2 study was to compare the efficacy of an association with ibrutinib and venetoclax
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::65bedb9c3fa7769cd84a4d2557a0f89f
https://doi.org/10.1182/blood-2021-145624
https://doi.org/10.1182/blood-2021-145624
Autor:
Andreas, Rosenwald, Susanne, Bens, Ranjana, Advani, Sharon, Barrans, Christiane, Copie-Bergman, Mad-Helenie, Elsensohn, Yaso, Natkunam, Maria, Calaminici, Birgitta, Sander, Maryse, Baia, Alexandra, Smith, Daniel, Painter, Luu, Pham, Shuchun, Zhao, Marita, Ziepert, Ekaterina S, Jordanova, Thierry J, Molina, Marie José, Kersten, Eva, Kimby, Wolfram, Klapper, John, Raemaekers, Norbert, Schmitz, Fabrice, Jardin, Wendy B C, Stevens, Eva, Hoster, Anton, Hagenbeek, John G, Gribben, Reiner, Siebert, Randy D, Gascoyne, David W, Scott, Philippe, Gaulard, Gilles, Salles, Catherine, Burton, Daphne, de Jong, Laurie H, Sehn, Delphine, Maucort-Boulch
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 37(35)
The study cohort included patients with histologically confirmed DLBCL morphology derived from large prospective trials and patient registries in Europe and North America who were uniformly treated with rituximab plus cyclophosphamide, doxorubicin, v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d66590b9c6735c0931e3500e794ebd44
https://pubmed.ncbi.nlm.nih.gov/31498031
https://pubmed.ncbi.nlm.nih.gov/31498031
Autor:
Muriel Rabilloud, Benjamin Riche, Jean François Etard, Mad-Hélénie Elsensohn, Nicolas Voirin, Thomas Bénet, Jean Iwaz, René Ecochard, Philippe Vanhems
Publikováno v:
PLoS ONE, Vol 17, Iss 1, p e0261756 (2022)
BackgroundWorldwide, COVID-19 outbreaks in nursing homes have often been sudden and massive. The study investigated the role SARS-CoV-2 virus spread in nearby population plays in introducing the disease in nursing homes.Material and methodsThis was c
Externí odkaz:
https://doaj.org/article/3cd327913aca485095e3ba72a94eb11b